SI-BONE (SIBN:NASDAQ) Annual Reports & Investor Relations Material

Overview

Medical device company SI-BONE, Inc. has made notable strides in the arena of musculoskeletal disorder treatment with its implantable devices. Designed to address sacropelvic anatomy issues, the company's minimally invasive surgical implant system offers a solution to ailments like sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma not only in the US market but also internationally. SI-BONE is furthering its breakthroughs with iFuse-3D, a titanium implant boasting a proprietary 3D-printed porous surface and fenestrated design, and iFuse-TORQ, a set of 3D-printed threaded implants that specifically tackles pelvic trauma. The company's direct sales force, along with agents and distributors, has helped it garner widespread adoption of its groundbreaking products. With headquarters in Santa Clara, California, SI-BONE was established in 2008.

Frequently Asked Questions

What is SI-BONE's ticker?

SI-BONE's ticker is SIBN

What exchange is SI-BONE traded on?

The company's shares trade on the NASDAQ stock exchange

Where are SI-BONE's headquarters?

They are based in Santa Clara, California

How many employees does SI-BONE have?

There are 201-500 employees working at SI-BONE

What is SI-BONE's website?

It is si-bone.com

What type of sector is SI-BONE?

SI-BONE is in the Healthcare sector

What type of industry is SI-BONE?

SI-BONE is in the Medical Appliances & Equipment industry

Who are SI-BONE's peers and competitors?

The following five companies are SI-BONE's industry peers:

- OrthoPediatrics

- SI-BONE

- ConforMIS

- STERIS

- Integer